ABSTRACT: Brain-machine interfaces (BMI) seek to directly communicate with the human nervous system in order to diagnose and treat intrinsic neurological disorders. While the first generation of these devices has realized significant clinical successes, they often rely on gross electrical stimulation using empirically derived parameters through open-loop mechanisms of action that are not yet fully understood. Their limitations reflect the inherent challenge in developing the next generation of these devices. This review identifies lessons learned from the first generation of BMI devices (chiefly deep brain stimulation), identifying key problems for which the solutions will aid the development of the next generation of technologies. Our analysis examines four hypotheses for the mecha nism by which brain stimulation alters surrounding neurophysiologic activity. We then focus on motor prosthetics, describing various approaches to overcoming the problems of decoding neural signals. We next turn to visual pros thetics, an area for which the challenges of signal coding to match neural architecture has been partially overcome. Finally, we close with a review of cortical stimulation, examining basic principles that will be incorporated into the design of future devices. Throughout the review, we relate the issues of each specific topic to the common thread of BMI research: translating new knowledge of network neuroscience into improved devices for neuromodulation.
I. INTRODUCTION
Since Penfield's first studies using electrical stimula tion of the brain, the possibility of altering neuronal function in a specific and predictable way to reverse disease or enhance function has motivated count less human and animal studies. Further pioneering work with subcortical stimulation introduced the idea of chronic, implantable stimulation devices to alter brain function. 1 Significant recent advances in our ability to directly monitor and stimulate neural circuits, coupled with a greater understanding of how activity within these circuits reflects and affects behavior and action, suggest that we have entered ABBREVIATIONS a new period of development in which devices that can diagnose and treat neurological disorders will become increasingly available.
The general principle guiding the development of these devices, known as brain-machine interfaces (BMI), is based on the past century of neuroscience research, which has demonstrated that neural func tion can be recorded, computationally modeled, and ultimately manipulated. Engineering efforts that take advantage of this wealth of knowledge are aimed at developing devices that can directly communicate with the human nervous system. The clinical successes realized in addressing cardiac disorders, where devices such as pacemakers and implantable cardiac defibrillators have been de veloped to manipulate cardiac physiology through closed-loop stimulation, serve as a precedent for their neurological analogs.
The development of the next generation of BMIs, however, will critically depend on overcom ing major scientific and engineering hurdles. For example, it has become clear that sensory and motor systems, let alone higher-level functions, involve multiple overlapping areas of the brain that coordinate activity together in a complex man ner. Furthermore, major goals in engineering any such device include ensuring long-term recording stability in an in vivo environment, identifying op timal surgical implantation techniques to decrease tissue damage and consequent inflammation, and quantifying stimulation parameters that optimally manipulate neural activity in a controlled and pre dictable manner. Addressing these goals represents the focus of research for many groups working on the development of BMIs today.
The goal of this review is to render a sketch of a central problem of BMI: translating network neu roscience into more complex and effective devices capable of communicating directly with the central nervous system. We attempt to achieve this goal by examining the most successful of the devices presently used to interface with the human nervous system, and to describe how each addresses a dif ferent problem of interaction with a complex neural environment. The multidisciplinary nature of BMI research warrants a much more expansive explora tion into areas such as tissue engineering, software algorithms, materials testing, and advanced model ing. We focus on lessons gleaned from experience with clinical devices, but our treatment of the prob lem is by no means exhaustive. This review will begin by exploring the evi dence describing the neurophysiologic mechanisms of deep brain stimulation and vagal nerve stimu lation in an attempt to outline how some of the aforementioned challenges have been addressed. Describing the evidence for different theoretical explanations, from modulation of neuronal firing rates to the disruption of network synchrony, will lay the foundation for understanding how BMIs can one day be used to induce controlled neuronal activity and to elicit predictable behavior. Further more, exploring the physiological mechanisms un derlying these open-loop devices will yield insight into how these BMIs can ultimately be engineered in a closed-loop system. This review will continue by examining the development of motor and visual prostheses, two open-loop BMI systems whose long-term devel opment will ultimately depend on the development of effective techniques of electrical stimulation. Exploring the world of motor prosthetics will shed light upon the various decoding schemes used to extract information from the nervous system. The next generation of motor prostheses will of course need to refine these methods of extraction as well as incorporate stimulation technology in a single closed-loop system. Visual prosthetics represent a more ambitious challenge, because they seek to ac tually recapitulate the neural circuitry itself before communicating that information to viable tissue. Hence, the challenge here lies not only in stimu lation, but in developing computationally efficient algorithms for encoding.
Finally, this review will investigate some of the hypothesized mechanisms of cortical stimulation in order to return once again to one of the fundamental challenges facing BMIs: how to electrically stimu late neural tissue to appropriately convey informa tion. Ironically, the neurophysiologic processes that underlie cortical stimulation are probably the most poorly understood, even though Penfield's work is over 50 years old.
II. DEEP BRAIN STIMULATION FOR PARKINSON'S DISEASE II.A. Background
Deep brain stimulation (DBS) has been used to treat over 80,000 people worldwide since its de velopment.
2 DBS was a significant advance in the development of early BMIs capable of communi cating with and modulating the central nervous sys tem. 3 DBS has been found to be especially effective in the treatment of Parkinson's disease and other movement disorders, although the role of DBS has recently expanded to other neurological disorders. 4 The core clinical features of Parkinson's disease, a neurodegenerative disorder primarily affecting the dopamine-producing cells of the substantia nigra, are distinguished by resting tremor, bradykinesia, and rigidity. 5 Traditional neurosurgical approaches to the treatment of such disorders included thala motomy, pallidotomy, and subthalamotomy; these fell out of favor because of complications, technical challenges, and the emergence of levadopa therapy in the 1970s. However, serendipitous intraopera tive observations that high-frequency stimulation reversibly suppressed tremors led to the emer gence of DBS for medically refractory Parkinson's and essential tremor. 6,7 DBS has a low side-effect profile: rates of hemorrhage from electrode place ment are less than 1%, and the incidence of other severe complications is lower than for most cranial surgeries. 4, 8 The most common complications are related to wound infection, skin erosion over the electrodes, or wire breakage. These occur at around 4% per electrode over its lifespan, which can be lon ger than 20 years for some patients. 8 A low-morbid implantation procedure and clinical effectiveness in an otherwise inexorable condition help explain why clinicians have sought to apply DBS to novel loca tions. Routine targets for intervention now include the ventral intermediate nucleus of the thalamus, globus pallidus, and the mainstay of therapy, the subthalamic nucleus.
Despite the clinical efficacy of DBS and 20 years of experience with the procedure, the precise neurophysiological mechanisms that underlie this first-generation BMI remain poorly defined. DBS for Parkinson's reflected rational BMI design to some degree: the circuitry of the basal ganglia was thought to be well understood. Electrical stimula tion seemed like reversible lesioning initially. But subsequent investigations have failed to pinpoint the details of the mechanism by which DBS ex erts its effects. The attempt to answer this question led to interesting new insights about the effects of stimulation on brain tissue, novel anatomic con nections, and hitherto lightly regarded phenomena such as the role of pathological oscillatory activity in the basal ganglia. This question has practical im plications for patient selection and the determina tion of stimulation parameters for DBS. The latter is currently an empirical procedure that can waste battery life and lead to a delay in achievement of clinical effectiveness. Identifying stimulation pa rameters is difficult because the space of possible combinations of voltage, current, pulse width, and waveform characteristics is large. A limit of 30 µC/ cm of charge density is considered safe based on animal studies. 9 Standard Medtronic DBS elec trode contacts have a surface area of 0.06 cm with an impedance of 500 Ω. 2 Stimulation is normally undertaken at a voltage of 1-3.5 V and a frequency greater than 50 Hz. Higher frequencies often elicit better clinical results, although they reduce battery life. 9 A setting of 130 Hz is common, achieving an average battery life of 5 years with typical current amplitude of 3 mA. Certain targets (e.g., globus pallidus) require higher current or higher voltage to achieve effective stimulation (Fig. 1) .
What happens in the brain when these stimu lation parameters are applied is not yet clear. A detailed examination of the theories that attempt to explain the effects of DBS is instructive, since future devices that rely on both cortical and subcortical stimulation will benefit from a resolution of this question. The interaction of stimulation ef fects with local and distant neuronal connectivity is demonstrated by data for subthalamic nucleus stimulation. We focus on this target, for which the most data exist.
II.B. Physiological Mechanisms of Deep Brain Stimulation Surgery
According to the accepted model of the basal gan glia, direct projections from the caudate and puta men (striatum) to the internal segment of the globus pallidus (GPi) are physiologically balanced against indirect connections from the striatum, via the ex ternal segment of the globus pallidus (GPe), to GPi. Inhibitory connections from GPi to the motor nu cleus of the thalamus represent the net output of the basal ganglia. In this model, reciprocal connections between the subthalamic nucleus (STN) and the indirect pathway and dopaminergic inputs from the substantia nigra (SN) modulate the physiological balance, and hence the activity, of the basal ganglia. In Parkinson's disease, degeneration of dopaminer gic neurons in SN results in a shift in this balance to the indirect, inhibitory pathway, cascading into physiologic inhibition through connecting synapses to the thalamus and motor system beyond.
This classic model of basal ganglia circuitry is a useful point of departure for thinking about deep brain stimulation. Yet, attempts to understand the clinical effects of DBS based on the effect of stimu lation on individual neurons has proven surprisingly difficult. There are currently four working hypoth eses: (1) depolarization blockade, 10 (2) neurotrans mitter depletion, 11 (3) synaptic inhibition, 12 and (4) modulation of basal ganglia network activity. 13 
Hypothesis I
The first hypothesis is centered on stimulation ef fects on ion channels. In vitro slice preparations from rodent-model Parkinsonian animals have been used to demonstrate that high-frequency stimulation induces cessation of spiking activity in STN neurons. 10 This effect is achievable in the presence of receptor blockade, suggesting it does not require afferent synaptic stimulation, and ap pears to be centered on sodium currents.
Hypothesis II
The hypothesis of synaptic failure due to neu rotransmitter depletion posits that chronic highfrequency stimulation of STN cell bodies leads to efferent output, but that this rapidly depletes the synaptic terminal. 11 This has not been demonstrat ed unequivocally in STN in vitro or in vivo, and microdialysis findings contradict this theory. [14] [15] [16] In patch clamp studies, STN neurons have actually maintained their spiking output during high-frequency stimulation. 17, 18 The stimulation locked the STN neurons into a pattern of firing separate from spontaneous activity and induced a time-locked firing of STN efferent target neurons in the GPi. Patch clamp studies can report oscilla tory changes in membrane potential, but the act of creating a slice preparation necessarily eliminates the network dynamic effects of local field poten tials. Therefore, extrapolating from slice prepara tions with limited numbers of neurons exposed to the stimulating electrode to the effects of macroelectrode stimulation may not be accurate.
Hypothesis III
In vivo studies have suggested a slightly different story. Electrical stimulation in primates has been shown to elicit changes in firing rates of neurons in efferent nuclei consistent with activation of neurons near DBS electrodes. 19 Recordings from the human globus pallidus during an implantation surgery have demonstrated uniform inhibition of GPi neurons with adjacent high-frequency micro stimulation. 12 The relationship between the onset of stimulation and the inhibitory effect suggests that the time course was most consistent with ac tivation of the afferent inhibitory axons that fell on the cell bodies of GPi neurons. The activity pattern was not consistent with depolarization blockade. This study presents the most compelling evidence for effects of stimulation on a population of neurons. An important caveat to the findings of mi crostimulation studies (as in Dostrovsky et al. 12 ) is that attempts to explain the clinical effectiveness of deep brain stimulation by analogy may be partially misguided. The charge per unit area delivered by typical microstim electrodes is similar to that of DBS macroelectrodes. But the total number of axons and cell bodies affected by macrostimulation is much greater, establishing the possibility of com plicated interactions between neurons close to the stimulating electrodes and those further away. The total amount of charge delivered also makes it more likely that macroelectrodes are able to alter local field potentials established by larger ensembles of neurons. Microelectrode recordings from different basal ganglia sites in the setting of macroelectrode active stimulation would be especially enlighten ing in this regard, although it raises some technical challenges.
Ultimately, interpreting data about the neuro physiological effects of brain stimulation requires answering a seemingly straightforward question: does spiking activity increase or decrease in a brain structure that is being stimulated? In general, highfrequency stimulation (>50 Hz) seems to cause clinical effects similar to those elicited by lesioning procedures, suggesting that stimulation should de crease spiking. For STN, evidence is actually split on this matter. Data from human in vivo microelectrode recording does suggest that spiking activ ity decreases with high-frequency stimulation. 20, 21 However, microdialysis data suggest that stimula tion actually increases glutamate output from syn aptic targets of STN neurons, [14] [15] [16] and animal data suggest that globus pallidus activity may actually increase with STN high-frequency stimulation, 19, 22 consistent with an increase in STN output activ ity. Finally, direct recordings imply that single-unit activity may actually increase. 18 
Hypothesis IV
It may be the case that the effects of stimulation are heterogenous across different types of neu rons and different regions. An alternative strategy for explaining the effects of DBS relies on local field potentials rather than alterations in singleunit activity within the direct/indirect paradigm. Field potentials are the summed effect of neuronal activity in a brain region generated by both local and distant populations. BMIs that rely on field potential modulation are appealing because they bypass the confounding effects of macroelectrode brain stimulation on single-unit activity. Given the complex effects of applying electrical current to groups of neurons in a three-dimensional space, field potential modulation may be the appropri ate level of abstraction at which to consider and model the effects of brain stimulation. For DBS for Parkinson's, a compelling field potential theo ry centers on the disruption of pathological beta band (12-20 Hz) synchrony by high-frequency STN stimulation.
II.C. Network Synchrony and Disruption
Human and primate data demonstrate that the basal ganglia of Parkinson's patients show a betaband oscillation of substantially greater power than normal controls. [23] [24] [25] This oscillation, which is syn chronous across different brain sites, is abolished in the period immediately before an individual ini tiates a movement, suggesting it contributes espe cially to the bradykinesia and rigidity that are the harbingers of worsening symptoms in the disease. 26 In mptp-induction models of Parkinson's in mon keys, the beta oscillation becomes more synchro nous and powerful as the symptoms of the disease take hold in the treated animals. 23 The beta-band oscillation is detectable over the motor cortex of Parkinson's patients, but not normal controls, 26, 27 and the severity of freezing and bradykinesia are correlated with the power of the oscillation, strongly suggesting the role of the oscillation in the genesis of the negative symptoms of Parkinson's. 23 The beta oscillation entrains the spiking activity of STN neurons, and is coherent across both subthalamic nuclei bilaterally and with a beta-band oscillation in the globus pallidus. 28 Most notably, dopaminergic medication exhibits a doserelated attenuation of the beta oscillation in both STN and the globus pallidus. 29 High-frequency stimulation has been shown to disrupt beta-band synchrony oscillation in an effect that persists for a variable period after the termination of stimula tion, but can last for over half an hour. 30 All told, there is not yet a consensus on the role of the beta oscillation in pathogenesis for Parkin son's; some researchers believe it is an epiphenom enon related to some other underlying process and does not have a causal role. But theories based on disruption of beta synchrony are more consistent with existing data and clinical observations than those based on alterations in spiking activity. The mechanism by which stimulation disrupts beta synchrony is not immediately obvious; that may require a re-examination of single-unit neuro physiological data. With what is available, however, the evidence for the theory of beta synchrony dis ruption is certainly more consistent than the data regarding STN spiking activity and microdialysis, which show a mix of increased and decreased effect from stimulation.
It is our opinion that the stimulation of inhibi tory afferents, as suggested by data from GPi, 12 is commensurate with the disruption of beta synchro ny in the basal ganglia as a mechanism of action for DBS. It has been demonstrated theoretically and experimentally that reciprocal inhibition can establish oscillatory synchrony in recurrent loops of neurons, although this is strongest in the gamma band (for a review, see Wang 31 ). With longer pe riods, beta oscillations are more likely to exhibit long-range synchrony across the structures of the basal ganglia. Both in vivo and in vitro studies may prove useful in elucidating this question.
III. BRAIN-MACHINE INTERFACES FOR EPILEPSY
The electrophysiological hallmark of seizure activ ity seen in epilepsy is abnormal excitability and synchronization of neuronal activity in the brain. For the 50 million patients affected by this disor der, the mainstay of therapy has been the use of anti-epileptic medication that prevents seizure ac tivity through a variety of mechanisms by suppress ing ion-channel activity. Despite maximal medical therapy, however, roughly one-third of patients with epilepsy suffer from persistent seizures. 32 Contin ued efforts to treat this neurological disorder medi cally over the past two decades have succeeded in improving the adverse effects of medication, but not in decreasing seizure frequency.
III.A. DBS for Epilepsy

Rationale
Based on the clinical successes enjoyed by DBS for movement disorders, and because at its essence, seizure activity in epilepsy represents pathological network activity, attention has recently been turned to using BMIs to address this neurological disorder.
In principle, such devices should electrically modu late neuronal firing to disrupt pathological synchro ny and reduce seizure activity. As with Parkinson's, the relationship between synchrony and epilepsy is complicated. During an epileptic event, syn chronization across different cortical and subcorti cal regions leads to tonic-clonic activity and loss of conscious awareness. 33 This is mostly in lowerfrequency bands, although gamma-band (>34 Hz) activity seems to precede epileptic discharges. Syn chronization appears to be more prevalent within rather than between cortical regions, even during generalized seizures. 34 Targets for DBS for epilep sy have so far focused on subcortical structures, for which stimulation is thought to disrupt the genera tion of more widespread synchronous networks.
Epileptic activity is thought to propagate through discrete and well-described anatomic lo cations in the brain. Although the circuit of Papez was initially implicated in emotional processing, this classic circuit has gained recent attention as a possible site of epileptic propogation. 35 The circuit of Papez links exiting fibers from the hippocampus to the mamillary bodies, which in turn project to the anterior nucleus of the thalamus. This nucleus communicates with the cingulate gyrus, which in turn projects to the hippocampus via the parahip pocampal gyrus and entorhinal cortex. 36 The mechanisms by which BMIs can at tenuate seizure activity are likely similar to the mechanisms that underlie the success of DBS for movement disorders. If seizures propagate along known circuitry, then interrupting this circuit with electrical stimulation could potentially pre vent the generation and propogation of seizure activity. DBS adopts this strategy. Vagal nerve stimulation also disrupts cortical EEG synchrony, but rather than preventing the propagation of an evolving seizure, it seems to reduce the onset of ictal activity. An examination of devices adopting this approach and currently under investigation may reinforce the notion that electrical stimula tion may disrupt network activity in order to elicit clinical effects.
Anterior Thalamic Deep Brain Stimulation
The notion of chronic stimulation of subcortical structures to treat refractory epilepsy has a history beginning with the use of cerebellar hemispheric stimulation, although clinical efficacy for this ap proach was never proven in a randomized study. [37] [38] [39] [40] The anterior thalamus was thought to play a role in kindling and epileptogenesis based upon imaging data showing volume loss in the anterior thalamic nucleus (ATN) with ongoing, poorly controlled seizure activity. [41] [42] [43] Animal data testing the abil ity of ATN stimulation to alter seizure activity demonstrated that it can delay the development of status epilepticus in rat models of epilepsy. [44] [45] [46] Low-frequency ATN stimulation elicits a synchro nous response in cortical recording sites (a driving rhythm, part of the implantation procedure), while high-frequency parameters are used for clinically efficacious stimulation. 47 These promising animal and anatomic un derpinnings led groups to attempt small-scale implantation programs under local investigational institutional review boards. [48] [49] [50] The safety of these early trials prompted the ambitious SANTE (stimulation of the anterior thalamus in epilepsy) trial. 51 SANTE was a randomized, controlled trial that showed a significant seizure benefit for ATN stimulation that seemed to improve in the months that followed implantation. This led to FDA ap proval for ATN stimulation, adding it to the arma mentarium for the treatment of refractory epilepsy.
SANTE specified localized onset, second arily generalized epilepsy for inclusion in the trial, based on the theory that such seizures would recruit the ATN as they propagated through the cortex. 47, 5 Electrographic seizure activity, by defini tion, includes high-amplitude, highly synchronous sub-gamma oscillatory activity that entrains mul tiple cortical areas. 34 Stimulation that successfully interrupts seizures disrupts this synchrony. Lowfrequency stimulation has a clinically deleterious effect. What will prove most interesting, as with vagal nerve stimulation (VNS), is evidence of in terictal changes in oscillatory activity, including gamma-and theta-band synchrony. It may be the case that there is an acute benefit from ATN stim ulation due to the disruption of ongoing seizure activity, and a more chronic improvement in seizure response based on interictal desynchronization, as with VNS. As more patients undergo ATN DBS, data for this question should become available. The future of subcortical stimulation to disrupt seizures hinges on the longevity of the effect ob served in the SANTE trial. Morbidity rates during implantation and hardware failure will likely be similar to those reported for DBS for movement disorders. 4, 8 If seizure reduction exceeds the ∼40% rate reported for VNS, it may become the preferred therapy for medically refractory cases not amenable to surgical resection of tissue. The quality of life of epilepsy patients is directly proportional to seizure frequency, and given the mild side-effect profile of ATN stimulation this will likely govern the number of patients who ultimately undergo implantation. 52 ATN stimulation has led to several patients who became seizure free (14 patients seizure free for a median of 6 months), although the longevity of this result has not been established. Similarly, the seizure profile of patients who benefit most from ATN stimulation remains to be established. Its next application may be for patients with localizedonset seizures from foci near eloquent cortex.
III.B. Desynchronization and Vagal Nerve Stimulation
Similar to DBS for epilepsy, the mechanism of the effect of vagal nerve stimulation is not certain, but the low morbidity of the implantation procedure and the well-tolerated side-effect profile has led to the widespread adoption of VNS for cases of refractory epilepsy. Pioneering work in the 1980s (e.g., Terry 53 ) led to several successful trials with sizable enrollments (see Table 1 ). The observation Vagal nerve stimulation may also achieve its clinical effects via network desynchronization. High-frequency, but not low-frequency vagal nerve stimulation can suppress interictal spiking activity, and VNS has been shown to increase REM sleep periods in both animals and humans. 66, 67 Animal data have long suggested an immediate decrease in EEG synchrony following the initiation of VNS at 30 Hz. 68 Investigations into the network activity seen in epilepsy have demonstrated that low-frequency synchronization with gamma-band desynchroniza-tion occur in cortical regions immediately before the onset of seizure activity. 33, 69 In humans, VNS seems to elicit a preferential decrease in low-frequency os cillatory coherence with a concomitant increase in gamma-band coherence both within and between the hemispheres. 70, 71 The increase in gamma-band coherence may also account for the improvements in alertness and memory performance noted in patients following VNS implantation, although improvements in seizure control may account for this benefit separate from direct cognitive effects of nerve stimulation. 69, 72 The physiologic mechanism by which VNS leads to low-frequency EEG desynchronization is not clear. A possibility is that the solitary tract fibers stimulated by VNS may alter the activity of the locus coeruleus (LC). Vagal input to the LC has been demonstrated pharmacologically. 73 In animals, LC activation has been shown to decrease low-frequency oscillatory power and induce de synchronization. 74 This theory of VNS-mediated alterations in synchrony is commensurate with the attentional improvements that follow VNS, given the role of the LC in modulating alertness.
III.C. Closed-Loop Brain-Machine Interfaces for Epilepsy
Responsive Stimulation
While VNS and ATN DBS have yielded some clinical benefit, they are open-loop systems that offer constant one-way stimulation of the central nervous system. 47 A more nuanced approach com mensurate with the next generation of BMIs would function to both detect and interrupt seizure activ ity, extending communication in both directions to achieve safer and more efficacious stimulation. This has been termed responsive stimulation, and it offers greater temporal specificity than open-loop systems because stimulation is delivered only when seizure activity is detected. 75 Theoretically, this allows more current to be delivered with less concern for chronic side effects. The first generation of such technolo gies is being developed and tested currently.
Cortical stimulation to achieve seizure inter ruption evolved from observations during macroelectrode stimulation mapping and from deep brain stimulation for epilepsy. Brief stimulation pulses delivered during a cortical afterdischarge were observed to interrupt ongoing epileptiform activ ity. 76 This fact, combined with data for the ability of ATN stimulation to interrupt seizure propagation, led to the design of a responsive stimulation system applied to patients undergoing preoperative intrac ranial EEG monitoring. 77 This approach consisted of an algorithm to identify incipient seizure activ ity, and to use that information to control a Grass S12 stimulator to deliver pulses to interrupt the seizure.
NeuroPace
The NeuroPace RNS system (NeuroPace, Moun tain View, CA) uses these same principles in an implantable closed-loop device designed to disrupt seizure activity before it occurs. 78 Surface strip elec trode contacts are placed over the cortex in an area of seizure activity. The device uses a learning algo rithm to identify relevant features of an individual's seizures, and when it detects an oncoming seizure, it activates stimulation using an internally generated current. The details of the algorithm and the stimu lation parameters have not been made public, but NeuroPace literature suggests that the parameters are derived empirically rather than based on com mon features of seizure activity across individuals. 78 Different areas of cortex in different patients seem to require unique parameters to achieve optimum seizure reduction. A phase III trial for NeuroPace is currently in its closing stages, and data should be available shortly.
Closed-loop systems offer advantages in that they can operate independent of subjective human control, have extended battery life, and possibly have a better side-effect profile compared to openloop stimulation. 47 Grid microelectrode devices may offer improved signal detection and more re fined stimulation options for seizure interruption. 79 Ultimately, the effectiveness of responsive neuro stimulation depends on the ability of the detec tion system and analysis algorithm to accurately identify incipient seizure activity in the brain. This has proven difficult using surface encephalogra phy, 80 although the improved spatial resolution and high-frequency discernment of iEEG employed by NeuroPace seems to permit a degree of efficacious stimulation. With a sufficiently mild side-effect profile for the stimulation pulses intended to abort a seizure, the detection algorithm could be balanced in favor of sensitivity with less concern for specific ity. This will likely be an idiosyncratic parameter depending on ictal onset zone. The use of subdural microelectrode (40 micron) arrays for improved detection of "mini-seizures" appears promising for seizure prediction. 81 That the disruption of synchronous oscillatory activity may underlie the success of stimulation in Parkinson's and epilepsy suggests the possibil ity that other pathological conditions that involve abnormal synchrony may be targets for therapeutic intervention with DBS as well. There is evidence that oscillatory synchrony may be abnormally diminished in conditions such as schizophrenia, autism, and Alzheimer's disease. 82 For this reason, low-frequency, driving stimulation (as is used dur ing site localization in ATN stimulation 47 ) may be more appropriate than high-frequency stimulation. Noninvasive studies, such as magnetoencepha lography, could be applied to patients with these conditions, specifically looking for possible sites amenable to alterations in brain synchrony. 83 
IV. MOTOR PROSTHESES
Neuromotor prosthetics comprise a set of medical devices designed to restore voluntary movement in paralyzed patients. They are a type of open-loop BMI in which signals are extracted from the cen tral or peripheral nervous system, then decoded and used to control devices. Neural commands for voluntary movement are issued as electrical signals originating in primary motor cortex and can be recorded with varying degrees of fidelity and dif ficulty depending on the sensor technology em ployed. The goal is to detect signals that have the largest amount of information about movement that change as rapidly as the movement commands themselves change.
In motor disorders such as ALS, muscular dystrophy, and spinal cord injury, the individual can be cognitively normal and fully able to gen erate detailed movement plans using higher mo tor control structures. Likewise, in patients with congenital limb anomalies or who have suffered traumatic amputation of a limb, the nervous system may be completely normal up until the abnormal or missing extremity. Neuromotor prostheses either re-create actual lost function or generate a useful surrogate action to restore the ability of the person to interact with their environment.
Motor prosthetics comprise three primary com ponents: a sensor which records a neural signal, a decoder which derives a voluntary control command from that signal, and an effector, in which the result ing command makes something physically happen in the world (Fig. 2) . A variety of sensors, decoders, and effectors have been investigated for neuromotor prosthetics, and often distinct versions of each com ponent can be mixed in different combinations.
Because patients can witness and experience the effect of their voluntary control, all neuromotor prosthetics are, in theory, considered closed-loop. This designation is somewhat specious given what a true closed-loop BMI-one that senses neural activity, independently processes information, and feeds stimulation back to the nervous systemought to look like. Work is currently underway, however, to incorporate external tactile and direct cortical stimulation feedback to provide individuals with somatosensory and proprioceptive feedback in a manner more closely mimicking a healthy human motor control system.
IV.A. Decoding signals in residual nerve fibers, or adjacent muscle groups
In people who have lost a limb, or who have a de generative muscle condition such as a dystrophy, one could argue that recording as distally as possi ble in the spinal cord or peripheral nervous system would be ideal. In principle, the more peripheral one gets from the brain, the more simple, and hence straightforward to decode, the mapping of neural activity to desired voluntary movement. However, in general, peripheral control signals yield only a single degree of freedom so if multiple joints need to be controlled they must be done sequentially rather than in parallel. Several control signals can be derived from the peripheral nervous system. Electrodes placed on the skin surface can capture electromyographic (EMG) activity: decoding algorithms ranging from simple amplitude threshold rules to neural networks have been employed to generate signals to drive robotic prosthetic limbs. Although noninvasive, EMG is hampered by the variability in signal to noise caused by changes in electrode placement and skin moisture. More invasive approaches are currently in development incorporating probes that pen etrate within the nerve to chronically record and stimulate peripheral nerves, 84-86 but one of their major drawbacks is the need for microsurgery for implantation.
Targeted nerve re-innervation comprises a hybrid approach in which residual fibers are surgi cally transferred to novel muscle targets, such as the pectoralis major. Surface electrodes can record the EMG signal from the new target muscle, which acts as a natural biopotential amplifier of multiple, parallel distinct nerve signals. 87 Although this ap proach has offered the most impressive restoration of multi-degree-of-freedom control in human amputees, it suffers from the same drawbacks in herent in all noninvasive approaches, including skin breakdown, lower signal to noise, sensitivity to precise electrode positioning, and variable imped ance from sweating.
Recently, an approach marrying chronically im planted microelectronics to the technique of using muscle as biopotential amplifier has been initiated: residual brachial plexus or peripheral nerve fibers are being coaxed with neurotrophic-factor-eluting silicon tetrode assemblies already seeded with autologous muscle tissue. Individual nerve fibers could thus contact a single muscle-silicon-probe target for a long-term biocompatible and biostable interface; the electronics would continually record the single myofiber activity and wirelessly transmit it to a decoding chip housed in a robotic prosthesis worn by the amputee. 88 Another hybrid approach being explored is the use of engineered axons stretch-grown in vitro, with one end of the assembly cultured on a flat multielectrode array: once the axons are stretched to the desired length, the entire assembly is implanted just distal to residual nerve fibers in vivo. Preliminary tests have shown that such assemblies will interface chronically to the peripheral nervous systems in FIGURE 3. Examples of recording devices for brain-computer interfaces to restore movement. Scalp EEGs are noninvasive electrical sensors, whereas a range of chronically implantable devices exist to re cord neural activity. Only high-impedance electrodes on a multi-electrode array or microwires that may be affixed to a depth electrode can capture individual neuron action potentials; the majority of sensors capture local field potentials at various spatial resolutions.
animals and record neural signals. This approach leverages the features of axons being stretched ex vivo, thus bypassing the need of a patient's residual fibers to slowly regenerate long distances to find and link to a biostable electronic interface. 89 
IV.B. Decoding Signals in Motor Cortex
While motor prostheses that capture information from peripheral nerves offer an advantage in that the neural code at these distant sites is often rela tively straightforward and easy to extract, deriving more variable and complex signals directly from central nervous system may offer distinct advan tages. The precise feature which could be seen as a drawback-the rapid variability in how a particular area of motor cortex represents a distinct volun tary movement 90 -could also be envisioned as an advantage. With the proper decoding algorithm, an engineer could derive a much wider array of control signals from a single sensor with a much smaller footprint instead of having to record from a multiplicity of implanted sensors in the periph ery. Furthermore, recording directly from the brain may be the only method to derive control signals in patients for whom the corticospinal pathway is damaged.
Although corticospinal tract neurons originate in a variety of cortical areas, including premotor, supplementary, and primary somatosensory cor tices, the greatest density of this final-common pathway of fine voluntary movement is found in primary motor cortex of the precentral gyrus. Just as electrical stimulation of primary motor cortex (M1) causes contralateral limb movement, so too recording from this area can provide a control sig nal. Over the past few decades, multiple laboratories around the world have developed a large toolbox of decoding algorithms to map activity recorded from sensors either on the scalp or implanted in the subdural space or within the brain to drive com puters, communication devices, and effectors such as robotic arms or functional electrical stimulation of otherwise paralyzed muscles. Each sensor site (Fig. 3) and decoding approach has its own unique set of strengths and weaknesses. 91, 92 Whereas high-impedance probes implanted into the brain can record the waveforms of action potentials of multiple, individual neurons, larger, lower-impedance probes can be used to capture the lower-frequency oscillatory activity representing the summed synaptic input in the dendritic fields of thousands of local neurons. In general, the fur ther one moves a probe from the cortex, the lower the signal to noise and the larger the volume, and hence the population of neurons over which the electrical signal is summed. As with all BMI con trol signals, this phenomenon could be considered either an advantage or a drawback: on the one hand, signals derived from a larger population of neurons are more stable in their immunity to drop-out of particular individual neurons or precise placement of a sensor; on the other hand, they average away the distinct, parallel signals present in a given area of cortex. Because of the ease and safety of placing scalp electrodes, a tremendous amount of work has been devoted to deriving as reliable as possible control signals from the EEG. These so-called EEG BMIs usually fall into one of four main categories. One uses features of evoked potentials in response to unexpected stimuli to determine what item in a large two-dimensional on-screen array a person is attending to. 93, 94 Another approach requires participants to master voluntary feedback of corti cal potentials to move computer cursors or select targets on a screen. [95] [96] [97] In a third approach, eventrelated desynchronization of a resting-state 8-12 Hz rhythm can be detected with real or imagined movements, offering a signal capable of controlling high-degree-of-freedom three-dimensional trajec tories. 98 In a fourth approach, EEG signals can be artificially enhanced by presenting a person with a steady-state flickering stimulus, allowing a decoder to identify which stimulus a person is attending to and use this to make a selection or move a cur sor. 99 Not surprisingly, all the algorithms developed for scalp EEG can be deployed with intracranial electrodes as well. Every year, thousands of patients with pharmacologically intractable epilepsy are re ferred for phase III evaluation with implanted sub dural grids and depth electrodes to help clinicians localize seizure activity. These patients, who are monitored post-operatively for several weeks, have volunteered for numerous studies in which cortical surface recordings have reliably been able to decode a variety of voluntary movements and use them to drive computer input in real time. [100] [101] [102] A recent focus on decoding signals in the highgamma range ) has generated excite ment: free of the spatial filtering introduced by the skull, intracranial electrodes can record this higherfrequency activity with greater fidelity and spatial anatomic resolution than is possible on the scalp. Low-impedance electrodes machined at a smaller diameter and interprobe spacing than traditional subdural grid electrodes appear to be able to record from narrow columns of cortex and hence could afford more distinct, parallel input signals; these so-called micro-ECoG prototypes are just enter ing human trials at the time of this publication. 103 In addition, next-generation high-density multielectrode grids with embedded active electronics on a dissolvable silk backing, which are flexible and can appose and conform to gyri, have just been tested in animal studies and may offer a promising alternative to rigid ECoG for chronic intracranial recording. 104 To record the action potentials of individual neurons, probes implanted into the brain parenchy ma are necessary. This class of sensor has long been considered the ne plus ultra because the ensemble activity of multiple, distinct neurons has been felt to be the richest and most detailed representa tion of fine, voluntary movement that a physical, artificial device can record. These sensors comprise one or more high-impedance electrodes in close physical proximity to the large layer V Betz cells of the primary motor cortex. An early form of this sensor was a pair of microwire electrodes affixed inside a small glass cone filled with neurotrophic factors; these cone electrodes were able to chroni cally record neural activity from the primary motor cortex of patients with brainstem strokes that had rendered them completely quadriplegic. 105 In the past few years, several patients with spi nal cord injury and ALS have been implanted with silicon multi-electrode arrays. Whereas the cone electrodes had only a few channels and were fully implantable, using wireless infrared telemetry, the multi-electrode arrays comprise a 4×4 mm square with 100 electrodes (400-micron spacing) and have used percutaneous connectors affixed to the skull and exiting the scalp. For neuromotor prosthetics based on single-unit recordings, before decoding can occur the waveforms of raw voltage must be classified as action potentials or not. The need to record, amplify, multiplex, classify, and transmit these signals comprises an immense engineering challenge that only a handful of interdisciplinary laboratories have had success with. [106] [107] [108] Wireless prototypes capable of sending signals from this many channels at a 30-KHz sampling rate have just completed preliminary animal studies and would form the next step for human trials.
An alternative approach involves classifying the action potentials (also termed "spike sorting") in the implanted device itself. Instead of sending out a signal with a 30-KHz sampling rate, the waveforms are determined to be spikes or not in real time by the implanted device. Hence only the number and timing of spikes in a given time window need to be recorded and transmitted, dramatically decreasing the sampling rate for wireless transmission. 107 Neuromotor prosthetics based upon multi-unit ensemble recording ultimately map spike times onto a movement control variable, such as intended position of the hand in three-dimensional space or a particular gesture; algorithms to achieve this map ping range from simple linear regression to neural networks, hidden Markov models, principle and independent component analyses, and Bayesian decoders with Kalman filters. 89, [109] [110] [111] [112] A variety of these techniques have been employed successfully in nonhuman primates and in human patients to generate real-time dynamic control signals; the fact that such a variety of distinct methods can all yield similar performance-and all based on recording just a sparse subset of 10 to 100 cells from a pool of millions of corticospinal neurons-suggests that the true mechanism by which primate motor cortex represents and engages complex, voluntary movement has a large degree of redundancy.
All of the sensor types discussed, from in rtacortical probes to scalp electrodes, have been incorporated into BMIs that have been used to drive powered wheelchairs, to control devices such as televisions, light switches, and prosthetic limbs, and for functional electrical stimulation of muscles (Fig. 4) . [113] [114] [115] [116] Given that a large number of permu tations of distinct sensors and decoding algorithms have been successfully tested, the question arises how engineers and clinicians should go about se lecting and developing a particular combination to the point where it could be deployed in patients on a larger scale.
V. VISUAL PROSTHESES
Inspired by the remarkable success of cochlear and brainstem implants in restoring audition to adults and children with profound sensorimotor loss, physiologists, engineers, and clinicians have been intent on duplicating this achievement in creating a visual prosthesis to restore vision to the blind. One of the pioneers of neuroengineer ing, James Brindley, tackled this problem as long ago as 1960 with wireless radio telemetry driven stimulators placed atop the visual cortex in a hu man patient. 117 Despite these early promising proof-of-concept trials in human patients, success in creating a vi able visual prosthetic has not been forthcoming. In a sense, developing a visual prosthesis represents a more ambitious goal than the previously discussed open-loop BMIs. In this case, information from the visual world would need to be extracted and translated to a neural code to be conveyed to viable neural tissue. This represents a challenge on two fronts: encoding of visual information and stimula tion of neural tissue.
V.A. Retinal Devices
For patients who have an intact optic nerve but cannot transduce light to drive that nerve, such as in retinitis pigmentosa or macular degeneration, retinal prostheses represent the most obvious so lution to restoring vision. By recording visual in put, either on glasses-mounted cameras or with sensors in or on the eye itself, such a device can bypass a damaged retinal transduction system and drive ganglion cells in the optic nerve to enable vision. This approach is analogous to the cochlear implant, which can bypass a damaged organ of Corti to directly drive the vestibulocochlear nerve. Tiny multi-electrode arrays have been fabricated and implanted chronically along the inner reti nal surface in patients; these epiretinal implants drive the output ganglion cells to transmit signals out the optic nerve into the rest of the brain. Pi lot clinical trials have shown that this device has restored the ability to navigate in the environ ment. 118 After decussating at the optic chiasm, the major output of the optic pathways arrives at the lateral geniculate nucleus (LGN). This six-layered poste rolateral thalamic structure encodes and transmits information about the entire contralateral visual field and hence exists as an ideal target for pros thetic vision restoration. Pilot studies in nonhuman primates have shown that reliable percepts can be induced with electrode arrays penetrating the LGN; human trials have not yet been planned. 119 
V.B. Visual Cortex Devices
Following upon the heels of Brindley and col leagues, several groups have been focusing on sub dural and intracortical multi-electrode arrays in the primary visual cortex to restore vision. By com municating with higher-order visual centers in the brain, this approach offers both an advantage and a disadvantage. On the one hand, as in the motor prosthetic domain, such electrodes can easily access these areas of the cortex in order to induce neural activity representative of the visual scene. On the other hand, such an approach bypasses the com plexities of visual processing that take place in the retina and lateral geniculate nucleus, and rely in stead on a more simplified neural code that may not capture the nuances of visual information ex tracted by these structures. 117, [120] [121] [122] [123] VI. CORTICAL STIMULATION Cortical stimulation for motor, language, memory, and visual cortex mapping has been undertaken for over 60 years. It has seen widespread application intraoperatively to guide surgery. Extraoperative mapping can also be performed using surface elec trode contacts.The long, rich literature surrounding different parameters and philosophies for cortical brain stimulation is beyond the scope of this pub lication, but some interesting findings highlight the contrasts between cortical stimulation and the forms of stimulation previously discussed.
Three points are relevant. The first is that lowfrequency, higher-amplitude stimulation (<20 Hz) appears to have functional effects similar to highfrequency stimulation (>50 Hz) in the cortex, counter to data in deep brain stimulation and vagal nerve stimulation, in which grossly different functional effects are elicited with high versus low frequencies. 124 The second point is that clinically useful stimulation has so far been limited to motor cortex, sensory cortex, visual cortex, and language cortex. Higher cognitive functions and memory cannot routinely be mapped via conventional methods. 125, 126 The third point is that the animal literature contains several successful instances of microstimulation to achieve subtle insights into the functional properties of specific brain areas, from which we may derive lessons for examining higher cognitive function in humans and contemplating new technologies based on cortical stimulation. 127 
VI.A. Frequency for Stimulation
Cortical stimulation for functional mapping has been shown to be effective using low-frequen cy, high-current biphasic square-wave pulses (5 and 10 Hz), rather than the more conventional higher-frequency biphasic square-wave pulses (50 or 60 Hz). 124 The functional deficits and ef fects elicited were not statistically different from higher-frequency stimulation, and indeed fewer after discharges were initiated by the lower-fre quency technique. This is important because af terdischarges are epileptiform spiking that follows stimulation, and they necessitate the cessation of stimulation at a particular site to avoid a more generalized seizure. It is noteworthy that the high-frequency stimulation seems to be more epi leptogenic as compared to ATN or VNS, in which lower frequencies (<20 Hz) drive synchrony and associated epileptic activity. 47 
VI.B. Brain Functions Amenable to Stimulation Mapping
Cortical stimulation mapping is well understood for mapping motor function and language: at con ventional stimulation parameters, biphasic squarewave stimulation delivered via bipolar contacts pro duces movement when motor cortex is stimulated, causes sensation when sensory cortex is stimulat ed, inhibits speech when receptive or productive speech areas are stimulated, and elicits phosphenes when visual cortex is stimulated.The effect of corti cal stimulation on more complicated cognitive pro cesses, however, is not well understood. Stimulation has yet to yield a reproducible system for mapping working and long-term memory, mainly because of the difficulty in testing different cortical sites at multiple different parameters. 125, 128 Memory ex periments require assessing recall frequency after the presentation of many items. Reliable testing is therefore extraordinarily time-consuming, and testing at multiple parameters (up to a threshold that elicits after-discharges) is prohibitive. Mem ory is not like speech or motor function: stimulat ing at one particular cortical site does not produce memory-arrest in the same manner as speech ar rest. 125, 128 Clinically useful memory mapping may ultimately require some pre-test knowledge about the properties of functional memory networks, ob tained from passive analysis of EEG or iEEG data as subjects engage in memory tasks, apart from ac tive stimulation.
VI.C. Lessons from Microstimulation
Cortical stimulation is more difficult than stimula tion at subcortical sites such as the basal ganglia. The neuronal populations are more heterogenous, with a complex tangle of excitatory and inhibitory neuronal cell bodies and axons all receiving the effects of stimulation. Microstimulation is a very powerful tool to test hypotheses about the func tional role of neurons that have been identified via microrecordings, but its utility for treating disease or enhancing cognitive function may be limited be-cause its effects are predictable only in cortex with advantageous architecture. 127 Microstimulation in nonhuman primates is usually conducted at much higher frequencies than in human cortical mapping experiments (200 Hz, for example). Its application to human research will be facilitated by the intro duction of 40-µm grid electrodes, which will per mit better spatial resolution and more fine-grained stimulation. 79 Current macroelectrode contact stimulation may be too blunt to affect function in specific populations of neurons for functions more subtle than gross movement or speech comprehen sion. Applying cortical stimulation to problems such as memory and decision making may benefit from their introduction.
VII. CONCLUSION
The recent advances in neuroscience and engineer ing reviewed here suggest that viable brain-machine interfaces may emerge from the realm of science fiction into the reality of clinical medicine in the near future. First-generation BMI technology has realized significant clinical success in a wide variety of disorders, from Parkinson's disease and epilep sy to motor disorders. Yet despite their successes, these devices remain for the most part open-loop systems with as yet poorly understood mechanisms of action. The next generation of these devices will build upon this knowledge to incorporate more precise closed-loop electrical stimulation.
Modulation of network synchrony has emerged as a common feature underlying the success dem onstrated with some of these first-generation BMIs. A search for new targets for DBS should involve identifying possible abnormal patterns of synchrony in patients with diseases such as Alzheimer's disease. Furthermore, future applica tions of brain stimulation will build on the success of NeuroPace by using more fine-grained signal analysis and newer algorithms to enhance or alter neuronal functioning in a closed-loop manner. Using smaller microgrid electrodes may allow hu man cortical stimulation to approximate some of the success that microstimulation in primates has achieved.
The developments realized in the world of mo tor prostheses are encouraging, but highlight the need to effectively decode neural signals in order to provide effective control signals. Major efforts currently underway seek to address how best to capture this information and will likely improve with technological advances in the ability to in terface directly with the human nervous system. Ultimately, these motor systems will need to incor porate closed-loop feedback in the form of cortical stimulation in order to provide individuals with proprioceptive feedback that mimics the normal motor control system. The question of using BMIs for higher-order cognitive functions becomes somewhat more complex as significant advances in understand ing the neural circuits underlying these functions must first be realized. It is likely the case that these processes involve multiple areas of the brain in complex networks. Decoding these circuits poses the largest hurdle in moving BMIs to this domain, and nuanced stimulation algorithms at widespread cortical sites based upon this knowledge will likely be required to affect processes such as memory and decision making.
All told, the advances seen in the develop ment of BMIs over the past decode represent an extraordinary achievement. That BMIs have been introduced and accepted into the standard lexicon of medical and engineering research is a testament to both their success and to their promise.The chal lenges in moving these devices to the next genera tion are immense, but with the wealth of research devoted to these issues, these challenges may be successfully navigated in the near future.
